Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters

Journal of Heart and Lung Transplantation

Volumn 30, Issue 4, 2011, Pages 408-413

  Greig, Douglas ^a   Alcaino, Hernan ^b   Castro, Pablo F ^a   Garcia, Lorena ^c   Verdejo, Hugo E ^a,c   Navarro, Mario ^c   Lpez, Rafael ^c   Mellado, Rosemarie ^a   Tapia, Fabiola ^c   Gabrielli, Luigi A ^a   Nogerol, Camilo ^c   Chiong, Mario ^c   Godoy, Ivan ^a   Lavandero, Sergio ^c,d,e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c Centro FONDAP Estudios Moleculares de la Celula   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

allopurinol; endothelial dysfunction; heart failure; oxidative stress; statins

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EXTRACELLULAR SUPEROXIDE DISMUTASE; GELATINASE B; MALONALDEHYDE; PLACEBO; SPIRONOLACTONE; URIC ACID;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMOKING; UNSPECIFIED SIDE EFFECT; URIC ACID BLOOD LEVEL; VASODILATATION;

ALLOPURINOL; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HEART FAILURE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PYRROLES; REGIONAL BLOOD FLOW; TREATMENT OUTCOME; XANTHINE OXIDASE;

EID: 79952745185     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.10.003     Document Type: Article

References (20)

1. D.J. Grieve, and A.M. Shah Oxidative stress in heart failure More than just damage Eur Heart J 24 2003 2161 2163 (Pubitemid 37522667)
2. P.F. Castro, D. Greig, and O. Perez Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 92 2003 215 218 (Pubitemid 36835976)
3. R.S. Vasan, L.M. Sullivan, and R. Roubenoff Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study Circulation 107 2003 1486 1491 (Pubitemid 36378485)
4. P.F. Castro, R. Miranda, and H.E. Verdejo Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity J Heart Lung Transplant 27 2008 435 441 (Pubitemid 351418248)
5. A.M. Deschamps, and F.G. Spinale Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation Cardiovasc Res 69 2006 666 676 (Pubitemid 43139729)
6. P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Pharmacol Rev 58 2006 87 114
7. U. Landmesser, S. Spiekermann, and S. Dikalov Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase Circulation 106 2002 3073 3078 (Pubitemid 35440291)
8. P. Castro, J.L. Vukasovic, and M. Chiong Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure Eur J Heart Fail 7 2005 1033 1039 (Pubitemid 41443599)
9. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 247 1972 3170 3175
10. A. Bittner, H. Alcaino, and P.F. Castro Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome Int J Cardiol 143 2010 98 100
11. G.W. Oliver, J.D. Leferson, and W.G. Stetler-Stevenson Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms Anal Biochem 244 1997 161 166 (Pubitemid 27030540)
12. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
13. ATS statement Guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
14. C.A. Farquharson, R. Butler, and A. Hill Allopurinol improves endothelial dysfunction in chronic heart failure Circulation 106 2002 221 226 (Pubitemid 34761303)
15. K. Ichimori, M. Fukahori, and H. Nakazawa Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form J Biol Chem 274 1999 7763 7768
16. J. George, E. Carr, and J. Davies High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 2006 2508 2516 (Pubitemid 44901524)
17. S.S. Daskalopoulou, V. Tzovaras, and D.P. Mikhailidis Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia Curr Pharm Des 11 2005 4161 4175 (Pubitemid 41679180)
18. D. Mozaffarian, E. Minami, and R.A. Letterer The effects of atorvastatin (10 mg) on systemic inflammation in heart failure Am J Cardiol 96 2005 1699 1704 (Pubitemid 41790394)
19. U. Landmesser, S. Spiekermann, and C. Preuss Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease Arterioscler Thromb Vasc Biol 27 2007 943 948 (Pubitemid 46606729)
20. H. Verdejo, H. Alcaino, and D. Greig Uric acid, xanthine oxidase and heart failure: unresolved issues Eur J Heart Fail 10 2008 1271 1272